Unichem Laboratories Share Price
Unichem Laboratories Share Price Today
As of 4 Jul 2026, Unichem Laboratories share price is ₹474.85. The stock opened at ₹467.65, compared to its previous close of ₹465.65. During today's trading session, Unichem Laboratories share price moved in the range of ₹455.00 to ₹478.50, with an average price of ₹466.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹278.20 and a high of ₹657.95. On the performance front, Unichem Laboratories share price has increased by 7.06% over the last six months and is down 19.03% on a year-on-year basis.
Unichem Laboratories Returns Calculator
Unichem Laboratories Shareholder Returns
Unichem Laboratories Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Unichem Laboratories Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,110.97 | ₹1,785.11 | ₹1,343.02 | ₹1,269.83 |
| Other Income | ₹35.32 | ₹31.59 | ₹38.52 | ₹47.51 |
| Total Revenue | ₹2,146.29 | ₹1,816.70 | ₹1,381.54 | ₹1,317.34 |
| Total Expenses | ₹1,991.70 | ₹1,844.05 | ₹1,519.33 | ₹1,294.31 |
| Profit Before Tax | ₹154.59 | -₹84.96 | -₹176.36 | ₹21.97 |
| Tax | ₹17.07 | ₹8.80 | ₹25.86 | -₹11.09 |
| Profit After Tax | ₹137.52 | -₹93.76 | -₹202.23 | ₹33.06 |
| EPS - Basic | ₹19.53 | -₹13.32 | -₹28.72 | ₹4.70 |
| EPS - Diluted | ₹19.47 | -₹13.32 | -₹28.72 | ₹4.68 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹154.59 | -₹84.96 | -₹176.36 | ₹21.97 |
| Income before WC changes | ₹303.29 | ₹112.36 | -₹43.52 | ₹102.43 |
| Change in Assets | -₹291.52 | -₹84.84 | -₹148.62 | -₹338.98 |
| Change in Liabilities | -₹2.37 | -₹7.15 | ₹119.26 | -₹15.45 |
| Change in WC | -₹293.89 | -₹91.99 | -₹29.36 | -₹354.43 |
| Cash flow from Operations | -₹7.02 | ₹14.00 | -₹85.09 | -₹259.61 |
| Cash flow from Investing | -₹241.23 | ₹50.40 | ₹202.81 | ₹102.40 |
| Cash flow from Financing | ₹183.76 | -₹106.31 | -₹81.30 | ₹191.23 |
| Total Cash Flow | -₹64.49 | -₹41.91 | ₹36.42 | ₹34.01 |
| Cash (Start of the year) | ₹154.75 | ₹183.75 | ₹109.20 | ₹77.46 |
| Cash (End of the year) | ₹89.58 | ₹154.75 | ₹183.75 | ₹109.20 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,539.93 | ₹1,531.63 | ₹1,604.58 | ₹1,670.38 |
| Current Assets | ₹2,029.47 | ₹1,743.32 | ₹1,588.47 | ₹1,648.39 |
| Total Assets | ₹3,569.40 | ₹3,274.95 | ₹3,193.05 | ₹3,318.77 |
| Current Liabilities | ₹991.97 | ₹737.60 | ₹639.60 | ₹552.13 |
| Net Current Asset | ₹1,037.50 | ₹1,005.72 | ₹948.86 | ₹1,096.27 |
| Non-Current Liabilities | ₹126.84 | ₹99.05 | ₹118.14 | ₹148.24 |
| Equity Capital | ₹2,450.59 | ₹2,438.30 | ₹2,435.30 | ₹2,618.41 |
| Total Equity & Liabilities | ₹3,569.40 | ₹3,274.95 | ₹3,193.05 | ₹3,318.77 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,735.70 | ₹1,442.16 | ₹1,072.43 | ₹942.93 |
| Other Income | ₹40.83 | ₹30.39 | ₹41.85 | ₹42.07 |
| Total Revenue | ₹1,776.53 | ₹1,472.55 | ₹1,114.28 | ₹984.99 |
| Total Expenses | ₹1,597.85 | ₹1,507.12 | ₹1,280.71 | ₹1,071.74 |
| Profit Before Tax | ₹182.68 | -₹92.18 | -₹279.09 | -₹86.75 |
| Tax | ₹19.72 | ₹0.00 | ₹20.61 | -₹31.32 |
| Profit After Tax | ₹162.96 | -₹92.18 | -₹299.70 | -₹55.43 |
| EPS - Basic | ₹23.15 | -₹13.09 | -₹42.57 | -₹7.87 |
| EPS - Diluted | ₹23.08 | -₹13.09 | -₹42.57 | -₹7.87 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹182.68 | -₹92.18 | -₹279.09 | -₹86.75 |
| Income before WC changes | ₹289.98 | ₹73.20 | -₹75.79 | -₹14.55 |
| Change in Assets | -₹220.23 | -₹76.80 | -₹141.73 | -₹127.48 |
| Change in Liabilities | ₹2.82 | -₹37.82 | ₹100.28 | -₹20.34 |
| Change in WC | -₹217.41 | -₹114.62 | -₹41.45 | -₹147.82 |
| Cash flow from Operations | ₹72.29 | -₹41.57 | -₹117.33 | -₹158.31 |
| Cash flow from Investing | -₹132.07 | ₹53.24 | ₹202.50 | ₹106.31 |
| Cash flow from Financing | -₹4.61 | -₹48.06 | -₹61.76 | ₹95.80 |
| Total Cash Flow | -₹64.39 | -₹36.39 | ₹23.41 | ₹43.81 |
| Cash (Start of the year) | ₹125.65 | ₹155.67 | ₹94.13 | ₹52.60 |
| Cash (End of the year) | ₹60.58 | ₹125.65 | ₹155.67 | ₹94.13 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,542.87 | ₹1,457.57 | ₹1,593.38 | ₹1,748.12 |
| Current Assets | ₹1,566.34 | ₹1,383.94 | ₹1,292.76 | ₹1,373.96 |
| Total Assets | ₹3,109.21 | ₹2,841.51 | ₹2,886.14 | ₹3,122.08 |
| Current Liabilities | ₹519.53 | ₹465.75 | ₹388.66 | ₹310.42 |
| Net Current Asset | ₹1,046.81 | ₹918.19 | ₹904.10 | ₹1,063.54 |
| Non-Current Liabilities | ₹129.93 | ₹81.13 | ₹113.21 | ₹139.63 |
| Equity Capital | ₹2,459.75 | ₹2,294.63 | ₹2,384.27 | ₹2,672.04 |
| Total Equity & Liabilities | ₹3,109.21 | ₹2,841.51 | ₹2,886.14 | ₹3,122.08 |
About Unichem Laboratories
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Unichem Laboratories Financial Highlights
- Revenue: Unichem Laboratories reported revenue of ₹2,264.91 crore in FY26 vs ₹2,146.29 crore in FY25. It showed an increase of 5.53% on a yearly basis.
- Operating Profit: Unichem Laboratories reported an operating profit of ₹292.38 crore in FY26 vs ₹154.59 crore in FY25. It showed an increase of 89.13% on a year-on-year basis.
- Net Profit: Unichem Laboratories reported a net profit of ₹252.84 crore in FY26 vs ₹137.52 crore in FY25. It showed an increase of 83.86% on a yearly basis.
Unichem Laboratories Quarterly Result Highlights
- Unichem Laboratories reported revenue of ₹598.59 crore in Mar 2026, compared with ₹532.97 crore in Dec 2025, representing an increase of 12.31% on a quarter-on-quarter (QoQ) basis.
- Unichem Laboratories reported an operating profit of ₹18.79 crore in Mar 2026, compared with ₹293.43 crore in Dec 2025, representing a decrease of 93.60% on a quarter-on-quarter (QoQ) basis.
- Unichem Laboratories reported a profit of ₹10.91 crore in Mar 2026, compared with ₹264.29 crore in Dec 2025, reflecting a decrease of 95.87% on a QoQ basis.
- The earnings per share (EPS) of Unichem Laboratories stood at ₹19.53 during Mar 2026.
Similar Stocks
FAQs on Unichem Laboratories Share Price
What is Unichem Laboratories share price today?
Unichem Laboratories share price is ₹474.85 as on 03 Jul, 2026, 15:29 IST.
How has the Unichem Laboratories share price performed in the past?
In the last 1 year, Unichem Laboratories delivered a return of -19.03%. The Unichem Laboratories share price hit a high of ₹657.95 and low of ₹278.20.
How much is the Mutual Fund shareholding in Unichem Laboratories shares?
The Mutual Fund Shareholding in Unichem Laboratories was 9.07% at the end of Mar 2026.
What is the the 52-week high and low of Unichem Laboratories shares ?
The 52-week high and low of Unichem Laboratories share is ₹657.95 and ₹278.20 as of 03 Jul, 2026.
What is the market cap of Unichem Laboratories?
The market capitalisation of Unichem Laboratories is ₹3,262.60 Crores as on 03 Jul, 2026.
What are the stock symbols of Unichem Laboratories?
The stock symbol of Unichem Laboratories is UNICHEMLAB on the NSE, 506690 on the BSE, and the ISIN is INE351A01035.
What was yesterday's closing price of Unichem Laboratories shares ?
Unichem Laboratories shares closed yesterday at ₹465.65 on NSE & ₹463.40 on BSE
How to buy Unichem Laboratories shares?
To buy Unichem Laboratories shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Unichem Laboratories shares on Holidays?
No, shares of Unichem Laboratories or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Unichem Laboratories shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Unichem Laboratories?
The PE and PB ratio of Unichem Laboratories is 12.9 and 1.2 respectively, as on 03 Jul, 2026, 15:29 IST.